|
|
|
Volumn 18, Issue 4 Suppl 3, 2009, Pages 1-5
|
|
Tumor necrosis factor inhibitors in the treatment of chronic inflammatory diseases. A review of immunogenicity and potential implications.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADALIMUMAB;
IMMUNOGLOBULIN G;
INFLIXIMAB;
MONOCLONAL ANTIBODY;
NONSTEROID ANTIINFLAMMATORY AGENT;
TNFR FC FUSION PROTEIN;
TNFR-FC FUSION PROTEIN;
TUMOR NECROSIS FACTOR ALPHA;
TUMOR NECROSIS FACTOR RECEPTOR;
ANTIBODY PRODUCTION;
DRUG ANTAGONISM;
DRUG EFFECT;
HUMAN;
IMMUNOGENETICS;
IMMUNOLOGY;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
ANTIBODIES, MONOCLONAL;
ANTIBODY FORMATION;
HUMANS;
IMMUNOGENETICS;
IMMUNOGLOBULIN G;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
RECEPTORS, TUMOR NECROSIS FACTOR;
TUMOR NECROSIS FACTOR-ALPHA;
|
|
EID: 68549109742
PISSN: 10623388
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (8)
|
|
References (21)
|
